Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy

Drug Design, Development and Therapy
Jeffrey D JenksMartin Hoenigl

Abstract

In recent decades, important advances have been made in the diagnosis and treatment of invasive aspergillosis (IA) and mucormycosis. One of these advances has been the introduction of isavuconazole, a second-generation broad spectrum triazole with a favorable pharmacokinetic and safety profile and few drug-drug interactions. Phase III trials in patients with IA and mucormycosis demonstrated that isavuconazole has similar efficacy to voriconazole for the treatment of IA (SECURE trial) and liposomal amphotericin B for the treatment of mucormycosis (VITAL trial with subsequent case-control analysis) and a favorable safety profile with significantly fewer ocular, hepatobiliary, and skin and soft tissue adverse events compared to voriconazole. As a result, recent IA guidelines recommend isavuconazole (together with voriconazole) as gold standard treatment for IA in patients with underlying hematological malignancies. In contrast to liposomal amphotericin B, isavuconazole can be safely administered in patients with reduced renal function and is frequently used for the treatment of mucormycosis in patients with reduced renal function. Updated guidelines on mucormycosis are needed to reflect the current evidence and give guidance on th...Continue Reading

Citations

Dec 18, 2018·Expert Review of Anti-infective Therapy·Jeffrey D JenksMartin Hoenigl
Mar 1, 2019·Medical Mycology·Jeffrey D JenksMartin Hoenigl
Jun 30, 2019·Mycoses·Oliver A CornelyUNKNOWN Mycoses Study Group Education and Research Consortium (MSG-ERC) and the European Confederation of Medical Mycology (ECMM)
Oct 17, 2019·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Daniela Dalla GasperinaPaolo Antonio Grossi
Mar 24, 2020·Current Fungal Infection Reports·Victoria M StevensTyree H Kiser
Jul 1, 2020·Journal of Fungi·Amir ArastehfarMartin Hoenigl
Sep 26, 2019·Current Fungal Infection Reports·Jeffrey D JenksMartin Hoenigl
Aug 22, 2018·Journal of Fungi·Jeffrey D Jenks, Martin Hoenigl
Jun 13, 2020·Antibiotics·Somanon BhattacharyaBettina C Fries
Apr 23, 2019·Case Reports in Transplantation·Imran GaniRajan Kapoor
Oct 17, 2019·Journal of Fungi·Elizabeth Dodds Ashley
Apr 9, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lauren FontanaMorgan Hakki
Dec 14, 2018·Journal of Fungi·Nikolaos Spernovasilis, Diamantis P Kofteridis
Sep 8, 2020·Expert Review of Anti-infective Therapy·Andrew M PeseskiHeiko Konig
Sep 6, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Martin Hoenigl
Jul 22, 2019·Fungal Genetics and Biology : FG & B·Margriet W J HokkenP E Verweij
Dec 3, 2020·Journal of Fungi·Misti Ellsworth, Luis Ostrosky-Zeichner
Dec 18, 2020·The Lancet Infectious Diseases·Philipp KoehlerUNKNOWN Infectious Disease Canada
May 27, 2021·Studies in Mycology·A ArastehfarM Hoenigl
Jul 7, 2021·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Kathrin RotheTobias Lahmer
May 26, 2021·Antimicrobial Agents and Chemotherapy·Antonio C ArrietaThomas J Walsh
Jul 31, 2021·Expert Review of Anti-infective Therapy·Daniel Echeverria-EsnalSantiago Grau
Sep 16, 2021·Expert Review of Pharmacoeconomics & Outcomes Research·C BeaucheminC Rotstein
Dec 23, 2021·Internal Medicine Journal·Abby P DouglasUNKNOWN Australasian Antifungal Guidelines Steering Committee
Dec 20, 2021·Therapeutic Drug Monitoring·Benjamin KablyEliane M Billaud

❮ Previous
Next ❯

Methods Mentioned

BETA
bronchoalveolar lavage

Clinical Trials Mentioned

NCT03149055
NCT03019939

Software Mentioned

FungiScope

Related Concepts

Related Feeds

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Related Papers

Therapeutics and Clinical Risk Management
Dustin T WilsonRichard H Drew
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Marisa H Miceli, Carol A Kauffman
Transplant Infectious Disease : an Official Journal of the Transplantation Society
John R WingardC S Roberts
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
M XueC Charbonneau
© 2022 Meta ULC. All rights reserved